What is Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP)?
Doxorubicin-cyclophosphamide-paclitaxel-trastuzumab-pertuzumab, also known as AC-THP, is a regimen used for the treatment of breast cancer. It contains the anticancer agents doxorubicin (Adriamycin®), cyclophosphamide, paclitaxel (Taxol®), trastuzumab (Herceptin®), and pertuzumab (Perjeta®).
Save up to 80% off your prescriptions!
We currently don't have enough shared data that is made public for this treatment.
Let's build this page together! When you share what it's like to have Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP) through your profile, those stories and data appear here too.
What are people saying about Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP)?
1
1
members have reported taking Doxorubicin-cyclphophosphamide-paclitaxel-trastuzumab-pertuzumab (AC-THP)